Insider filing
Traded Nov 16 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 16, 2026 · Filed Nov 18, 2026
A Windward Bio director paid $14.9M out of pocket for Windward Bio shares. 2 other people at Windward Bio bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Written by software from the filings listed below · Nov 19, 2026
5 more points, with the facts they come from, are in OQRO Pro.
Sign up freeopen market purchase
Code P — open-market or private purchase
~$14,875,000
Shares × reported transaction price
$1M+
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 16 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 16 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 16 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.